FPGT
ABBV icon

Financial Partners Group (Tennessee)’s AbbVie ABBV Stock Holding History

Financial Partners Group (Tennessee)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,310
Closed -$274K – 89
2025
Q1 		$274K Sell
1,310
-655
-33% -$127K 0.12% 76
2024
Q4 		$349K Buy
1,965
+192
+11% +$35.3K 0.15% 74
2024
Q3 		$350K Sell
1,773
-1,251
-41% -$233K 0.13% 80
2024
Q2 		$519K Buy
3,024
+632
+26% +$105K 0.2% 71
2024
Q1 		$436K Buy
2,392
+236
+11% +$40.7K 0.17% 74
2023
Q4 		$334K Buy
2,156
+26
+1% +$3.79K 0.15% 73
2023
Q3 		$318K Buy
2,130
+108
+5% +$15.9K 0.15% 72
2023
Q2 		$272K Buy
2,022
+222
+12% +$32.6K 0.14% 74
2023
Q1 		$287K Sell
1,800
-88
-5% -$13.5K 0.15% 68
2022
Q4 		$305K Buy
+1,888
New +$289K 0.18% 62

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Financial Partners Group (Tennessee)'s ABBV Position: Q2 2025 in Review

Financial Partners Group (Tennessee) sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,310 shares — an estimated $274K sold.

Financial Partners Group (Tennessee) first reported a position in ABBV in Q4 2022 and held it in 10 quarters. The position peaked at $519K in Q2 2024. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Financial Partners Group (Tennessee) reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Financial Partners Group (Tennessee) sold 1,310 AbbVie shares in Q2 2025, an estimated $274K.
  • Financial Partners Group (Tennessee) first reported a position in AbbVie in Q4 2022 and held it in 10 quarters.
  • Financial Partners Group (Tennessee)'s AbbVie position peaked at $519K in Q2 2024.
  • 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Financial Partners Group (Tennessee)'s 13F filing for Q2 2025, filed 17 Jul 2025.